SWA
Sutton Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-11
| Closed | -$231 | – | 1679 |
|
2022
Q3 | $231 | Sell |
11
-758
| -99% | -$15.9K | ﹤0.01% | 1547 |
|
2022
Q2 | $23.9K | Buy |
769
+757
| +6,308% | +$23.5K | 0.01% | 612 |
|
2022
Q1 | $493 | Hold |
12
| – | – | ﹤0.01% | 1486 |
|
2021
Q4 | $522 | Buy |
+12
| New | +$522 | ﹤0.01% | 1513 |
|
2020
Q3 | – | Sell |
-757
| Closed | -$59.9K | – | 1225 |
|
2020
Q2 | $59.9K | Hold |
757
| – | – | 0.03% | 264 |
|
2020
Q1 | $43.8K | Buy |
757
+3
| +0.4% | +$174 | 0.03% | 293 |
|
2019
Q4 | $40.7K | Hold |
754
| – | – | 0.02% | 368 |
|
2019
Q3 | $39.4K | Buy |
754
+201
| +36% | +$10.5K | 0.02% | 368 |
|
2019
Q2 | $26.7K | Hold |
553
| – | – | 0.02% | 485 |
|
2019
Q1 | $27.9K | Sell |
553
-90
| -14% | -$4.55K | 0.02% | 470 |
|
2018
Q4 | $38.1K | Buy |
643
+90
| +16% | +$5.34K | 0.02% | 330 |
|
2018
Q3 | $36.4K | Hold |
553
| – | – | 0.02% | 372 |
|
2018
Q2 | $27.9K | Hold |
553
| – | – | 0.02% | 463 |
|
2018
Q1 | $29.1K | Hold |
553
| – | – | 0.02% | 430 |
|
2017
Q4 | $25.7K | Hold |
553
| – | – | 0.02% | 464 |
|
2017
Q3 | $22.4K | Hold |
553
| – | – | 0.02% | 511 |
|
2017
Q2 | $18.8K | Buy |
553
+105
| +23% | +$3.56K | 0.01% | 549 |
|
2017
Q1 | $13K | Buy |
448
+174
| +64% | +$5.05K | 0.01% | 644 |
|
2016
Q4 | $9K | Hold |
274
| – | – | 0.01% | 719 |
|
2016
Q3 | $8.64K | Buy |
+274
| New | +$8.64K | 0.01% | 699 |
|
2016
Q2 | – | Sell |
-345
| Closed | -$12.5K | – | 1040 |
|
2016
Q1 | $12.5K | Buy |
+345
| New | +$12.5K | 0.01% | 551 |
|